These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23034254)

  • 1. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
    J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment.
    Ajami A; Hosseini SH; Taghipour M; Khalilian A
    Scand J Immunol; 2014 Jul; 80(1):36-42. PubMed ID: 24498860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
    Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.
    Angelucci F; Ricci V; Pomponi M; Conte G; Mathé AA; Attilio Tonali P; Bria P
    J Psychopharmacol; 2007 Nov; 21(8):820-5. PubMed ID: 17715210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.
    Grillo RW; Ottoni GL; Leke R; Souza DO; Portela LV; Lara DR
    J Psychiatr Res; 2007; 41(1-2):31-5. PubMed ID: 16546213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of serum BDNF levels in drug-naive patients with schizophrenia.
    Rizos EN; Rontos I; Laskos E; Arsenis G; Michalopoulou PG; Vasilopoulos D; Gournellis R; Lykouras L
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1308-11. PubMed ID: 18502013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence.
    Lee BC; Choi IG; Kim YK; Ham BJ; Yang BH; Roh S; Choi J; Lee JS; Oh DY; Chai YG
    Alcohol; 2009 Jun; 43(4):265-9. PubMed ID: 19560628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
    Pedrini M; Chendo I; Grande I; Lobato MI; Belmonte-de-Abreu PS; Lersch C; Walz J; Kauer-Sant'anna M; Kapczinski F; Gama CS
    Neurosci Lett; 2011 Mar; 491(3):207-10. PubMed ID: 21256922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
    Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
    Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse.
    Jockers-Scherübl MC; Danker-Hopfe H; Mahlberg R; Selig F; Rentzsch J; Schürer F; Lang UE; Hellweg R
    Neurosci Lett; 2004 Nov; 371(1):79-83. PubMed ID: 15500971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment.
    Lee AH; Lange C; Ricken R; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2011 Jun; 31(3):334-6. PubMed ID: 21508862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
    Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
    Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers.
    Angelucci F; Ricci V; Spalletta G; Pomponi M; Tonioni F; Caltagirone C; Bria P
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):882-7. PubMed ID: 18774699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress.
    Schulte-Herbrüggen O; Fuchs E; Abumaria N; Ziegler A; Danker-Hopfe H; Hiemke C; Hellweg R
    J Neurosci Res; 2009 Aug; 87(11):2551-60. PubMed ID: 19360902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
    Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.
    Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS
    Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
    Zakharyan R; Boyajyan A
    Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.